• Users Online: 334
  • Print this page
  • Email this page


 
 Table of Contents  
OPHTHALMIC IMAGES
Year : 2020  |  Volume : 58  |  Issue : 3  |  Page : 223

Fibrinous uveitis after transscleral diode cyclophotocoagulation


Department of Glaucoma, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India

Date of Submission29-Mar-2020
Date of Decision30-Apr-2020
Date of Acceptance01-May-2020
Date of Web Publication14-Sep-2020

Correspondence Address:
Dr. Vijayalakshmi A Senthilkumar
Department of Glaucoma, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/tjosr.tjosr_31_20

Get Permissions


How to cite this article:
Senthilkumar VA. Fibrinous uveitis after transscleral diode cyclophotocoagulation. TNOA J Ophthalmic Sci Res 2020;58:223

How to cite this URL:
Senthilkumar VA. Fibrinous uveitis after transscleral diode cyclophotocoagulation. TNOA J Ophthalmic Sci Res [serial online] 2020 [cited 2020 Oct 19];58:223. Available from: https://www.tnoajosr.com/text.asp?2020/58/3/223/294984



A 52-year-old male diagnosed as advanced primary open angle glaucoma in both eyes, developed uncontrolled intraocular pressure (IOP) despite maximal antiglaucoma medications. His best-corrected visual acuity and IOP were 6/9 and 6/6 and 46 and 22 mmHg in the right eye (RE) and the left eye (LE), respectively. We performed transscleral diode laser cyclophotocoagulation (TSCPC, Oculight SL × 810 nm, G-probe: Iridex Corporation, Mountain View, CA, USA) in the RE. Postoperatively, he was treated with steroid eye-drops and cycloplegics. Ten days later, he presented with severe pain and redness in the RE. Anterior-segment evaluation of the RE revealed severe fibrinous uveitis [Figure 1]. TSCPC first performed by Beckman, traditionally used only in eyes with end-stage glaucoma with little or no visual potential, has now become a popular minimally invasive treatment for glaucoma with good vision.[1],[2] As it is a cyclodestructive procedure, considerable posttreatment anterior uveitis is an anticipated sequela and may be minimized with preoperative use of anti-inflammatory therapy, especially in patients with good visual potential.[3]
Figure 1: (a and b, magnified) Slit lamp photography showing circumcorneal congestion with extensive fibrinous reaction in the anterior chamber

Click here to view


Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Beckman H, Kinoshita A, Rota AN, Sugar HS. Transscleral ruby laser irradiation of the ciliary body in the treatment of intractable glaucoma. Trans Am Acad Ophthalmol Otolaryngol 1972;76:423-36.  Back to cited text no. 1
    
2.
Egbert PR, Fiadoyor S, Budenz DL, Dadzie P, Byrd S. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol 2001;119:345-50.  Back to cited text no. 2
    
3.
Rotchford AP, Jayasawal R, Madhusudhan S, Ho S, King AJ, Vernon SA. Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol 2010;94:1180-3.  Back to cited text no. 3
    


    Figures

  [Figure 1]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
References
Article Figures

 Article Access Statistics
    Viewed67    
    Printed0    
    Emailed0    
    PDF Downloaded11    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]